methamphetamine has been researched along with p-aminohippuric acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Doi, Y; Hasegawa, T; Kitaichi, K; Matsushima, M; Morishita, Y; Takagi, K; Ueyama, J; Zhao, YL | 1 |
1 review(s) available for methamphetamine and p-aminohippuric acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for methamphetamine and p-aminohippuric acid
| Article | Year |
|---|---|
Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats.
Topics: Animals; Area Under Curve; Behavior, Animal; Brain; Carnitine; Carrier Proteins; Central Nervous System Stimulants; Cimetidine; Dialysis Solutions; Gene Expression Regulation; Kidney; Male; Membrane Proteins; Metabolic Clearance Rate; Methamphetamine; Motor Activity; Myocardium; Organic Cation Transport Proteins; p-Aminohippuric Acid; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium; Time Factors; Tissue Distribution | 2003 |